Finding Predispositions to Serious Drug Reactions
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
A better understanding of why some people are predisposed to dangerous drug interactions and serious illness is the charge of the newly formed group, International Serious Adverse Event Consortium (SAE). The Chicago Tribune's Bruce Japsen interviews SAE chairman and chief executive officer, Arthur Holden about this important subject.
Overview
A better understanding of why some people are predisposed to dangerous drug interactions and serious illness is the charge of the newly formed group, International Serious Adverse Event Consortium (SAE). The Chicago Tribune's Bruce Japsen interviews SAE chairman and chief executive officer, Arthur Holden about this important subject.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
The Importance of PD-L1 Testing: Shaping the Future of Treatment in ESCC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?